Janus Henderson Group PLC Fulgent Genetics, Inc. Transaction History

Janus Henderson Group PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$23.64 - $30.27 $254,153 - $325,432	-10,751 Reduced 9.78%	99,206 $2.87 Million
Q3 2023 Nov 14, 2023	BUY	$26.74 - $40.81 $766,876 - $1.17 Million	28,679 Added 35.29%	109,957 $2.94 Million
Q2 2023 Aug 14, 2023	BUY	$28.52 - $40.7 $592,645 - $845,746	20,780 Added 34.35%	81,278 $3.01 Million
Q1 2023 May 15, 2023	BUY	$29.39 - $36.27 $690,371 - $851,982	23,490 Added 63.47%	60,498 $1.89 Million
Q4 2022 Feb 14, 2023	SELL	$29.23 - $40.28 $114,756 - $158,139	-3,926 Reduced 9.59%	37,008 $1.1 Million
Q3 2022 Nov 14, 2022	SELL	$37.92 - $63.74 $13,499 - $22,691	-356 Reduced 0.86%	40,934 $1.56 Million
Q2 2022 Aug 15, 2022	BUY	$47.98 - $62.75 $396,794 - $518,942	8,270 Added 25.05%	41,290 $2.25 Million
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $486,386 - $937,745	-9,757 Reduced 22.81%	33,020 $2.06 Million
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $237,697 - $322,875	3,075 Added 7.75%	42,777 $4.3 Million
Q3 2021 Nov 16, 2021	SELL	$74.87 - $110.87 $594,692 - $880,640	-7,943 Reduced 16.67%	39,702 $3.57 Million
Q2 2021 Aug 16, 2021	BUY	$66.8 - $100.45 $3.18 Million - $4.79 Million	47,645 New	47,645 $4.39 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.